A 22-year-old male patient with no known history of hypertension was admitted to the emergency unit of the regional hospital in March 2011 with signs of pulmonary oedema and was found to have blood pressure (BP) of 220/ 140 mm Hg. Before hospitalization the patient reported progressive shortness of breath for 2 days. His BP was reduced by oral administration of captopril within few hours to 170/100 mm Hg. In addition, the patient was put on amlodipine 20 mg per day and bispoprolol 10 mg per day. After the patient was stabilized, he was transferred to the Department of Hypertension, Institute of Cardiology, Warsaw.
On admission BP was 170/118 mm Hg and heart rate was 56 beats and doxazosin (2 mg) was administered. Auscultation of the chest revealed rales heard over both lung fields and fundoscopy demonstrated hypertensive retinopathy grade IV. Ambulatory blood pressure monitoring (ABPM) showed mean BP 179/110 and 167/95 mm Hg during the day time and night time, respectively. Serum potassium was decreased with 2.6 mmol l . Albumin excretion was 60 mg per day. Other laboratory investigations were within normal limits. Electrocardiogram showed sinus rhythm and demonstrated left ventricular strain and hypertrophy (LVH) with a Sokolov-Lyon score of 65 mm. The chest X-ray revealed cardiomegaly and interstitial oedema. The patient's past medical history was unremarkable. The patient had never smoked. Hypertension family history was negative.
On echocardiographic examination LVH was shown. Systolic function assessed by ejection fraction was slightly decreased whereas function of longitudinal fibres assessed by speckle tracking-global longitudinal strain (GLS)-was depressed. Diastolic function was within normal limits ( Figure 1 ).
Kidney ultrasonography was normal. Renal artery stenosis was excluded by the angio-CT examination. An abdominal computed tomography (CT) examination revealed a 17-mm adenoma (2 Hounsfield units) in the right adrenal gland.
Serum aldosterone was increased to 61.2 ng dl À 1 (upper reference limit, URL 30 ng dl À 1 ), as well as urinary aldosterone excretion (45.3 mg per 24 h, URL 30 mg per 24 h), plasma renin activity was low 0.1 ng ml À 1 per 24 h. As on admission the patient manifested signs of pulmonary oedema, a saline infusion test or oral sodium loading test were not performed. Plasma metanephrines, plasma cortisol and plasma adrenocorticotropic hormone (ACTH) were within normal values.
For enabling a proper biochemical diagnostic workup bisoprolol was discontinued and after biochemical evaluation was completed it was again introduced. However, as the good BP control was difficult to achieve, ramipril (10 mg per day) was added.
After the diagnosis of primary aldosteronism (PA) was established the patient was put on spironolactone (50 mg per day and then 100 mg per day) which resulted in normalization of serum potassium (4.5 mmol l À 1 ) and improvement of BP control. After 4 weeks patient underwent uncomplicated laparoscopic removal of the adrenal adenoma, which was confirmed on histopathology. Spironolactone was discontinued, ABPM values as well as serum potassium concentration were within normal range while patient was receiving amlodipine (10 mg per day), ramipril (10 mg per day) and bisoprolol (5 mg per day). Because of the presented complications no attempt to decrease the number of drugs was made.
After 6 months the patient was readmitted for clinical evaluation. After surgical treatment the patient was asymptomatic, felt well and his physical status had substantially improved. ABPM values were within normal range (mean BP during the day 127/ 72 mm Hg and during the night 126/64 mm Hg). Antihypertensive medication was continued but doses were then reduced. Electrocardiogram demonstrated regression of signs of LV strain and hypertrophy with Sokolov-Lyon score of 35 mm.
Potassium and sodium plasma concentrations were within normal range. Serum creatinine was 125 mmol l À 1
. Albumin excretion had decreased to 10 mg per day. Serum and urinary aldosterone, as well as plasma renin activity were within normal range (ramipril and bisoprolol were discontinued before the evaluations). Fundoscopy demonstrated regression of hypertensive retinopathy to grade I.
On echocardiographic examination, regression of LVH as well as an improvement in parameters of systolic function were clearly observed. The improvement in the GLS was less pronounced (supplementary figure 1) .
We are presenting a 22-year-old patient with PA resulting in malignant hypertension, pronounced LVH and acute heart failure. Within 6 months after surgical treatment marked improvement in cardiac structure and function was observed.
In our patient it was difficult to establish the duration of hypertension. BP level and retinal vascular changes qualified for the diagnosis of malignant hypertension. In addition marked LVH with left ventricular failure were prominent.
Our case confirms that PA can result in malignant hypertension. 1 The course of the hypertensive heart disease after removal of the aldosterone producing adrenal adenoma provides evidence that PA was the cause of malignant hypertension with left ventricular failure in our patient.
On the basis of literature, the association of PA with malignant hypertension seems unusual and in the past 5 decades only a small number of cases of PA causing malignant hypertension has been reported. [1] [2] [3] It is remarkable that in the recent reports on cardiovascular complications in patients with PA, the incidence of malignant or accelerated hypertension was not reported. 4 It is unknown whether this should be ascribed to early recognition of PA before malignant hypertension can evolve or whether patients with PA remain undiagnosed after presentation with malignant hypertension.
Our presented patient was characterized by unusually marked LVH and mild deterioration of parameters of systolic function. After surgical treatment and during antihypertensive therapyincluding angiotensin-converting enzyme inhibitor-marked regression of LVH was documented by echocardiography showing also improvement of systolic function.
Nadar et al. 5 showed that patients with malignant hypertension had significant LVH in association with systolic dysfunction irrespectively of the duration of known hypertension. Also Gosse et al. 6 documented in 46 patients with malignant hypertension that at baseline they were characterized by important LVH and alteration in systolic function. Short-term follow-up (1-3 month) after treatment showed rapid improvement in systolic function together with significant LVH regression.
In our case significant LVH exceeded values reported in patients with malignant hypertension (LV mass height À 2.7 À 126 g m
vs mean 78 g m À 2.7 in the report by Gosse et al. 6 and LV mass/ index 685 g/340 g m À 2 vs mean 357 g/192 g m À 2 in the report by Nadar et al. 5 ). It can be speculated that in our patient both elevated BP and detrimental effect of excessive amounts of aldosterone on the heart and vasculature might independently contribute to the development of marked LVH. As a plausible mechanism it has to be noted that mineralocorticoid receptors are present in cardiomyocytes and are involved in cardiac remodelling. 7, 8 Moreover, it can be speculated that such remarkable LVH as seen in our patient might be partially explained by aldosterone-induced cardiomyocyte fluid retention. 9 On the other hand, aldosterone can also cause LVH irrespectively of direct effect on cardimyocytes through increases in intracardiac volumes and the accompanying increases in-wall stress. 10 The former and latter might also explain the rapid regression of LVH in our patient after surgical treatment.
In summary, our patient along with those reported previously, supports the concept that PA can result in malignant hypertension and left ventricular failure. This reiterates that patients with malignant hypertension, especially presenting with pronounced hypokalaemia, should be screened for PA.
What is known about this topic
Primary aldosteronism (PA) can be very rarely associated with malignant hypertension. It has been suggested that both elevated BP and excessive amounts of aldosterone may have detrimental effects on heart and vasculature.
Patients with malignant hypertension are characterized by left ventricular hypertrophy (LVH) and alteration in systolic function.
What this study adds It was documented that PA resulting in malignant hypertension may be associated with unusually pronounced LVH and acute heart failure.
In patients with malignant hypertension-especially presenting with pronounced hypokalaemia-PA should also be considered in differential diagnosis of identifiable causes of hypertension.
In patients with malignant hypertension and left ventricular failure, an early diagnosis of PA followed by proper treatment not only improves blood pressure but also result in marked improvement of cardiac structure and function.
